abstract |
The present invention provides a method for the treatment of psychiatric patients who have or are at risk of hepatic impairment, which comprises administering a therapeutically effective amount of paliperidone, its pharmaceutically acceptable acid addition salts, enantiomeric forms and esters thereof to said Psychiatric patient in need of it. |